Drug-induced sialorrhea

Drugs of Today

Volumn 41, Issue 6, 2005, Pages 411-418

  Freudenreich, Oliver ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; ATROPINE; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; BETHANECHOL; BOTULINUM TOXIN; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; CHOLINESTERASE INHIBITOR; CLONIDINE; CLOZAPINE; DONEPEZIL; EDROPHONIUM; FLUPHENAZINE; HALOPERIDOL; HEAVY METAL; IPRATROPIUM BROMIDE; MERCURY; NEOSTIGMINE; NEUROLEPTIC AGENT; OLANZAPINE; ORGANOPHOSPHATE INSECTICIDE; PHYSOSTIGMINE; PILOCARPINE; RESERPINE; RISPERIDONE; THALLIUM; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

ALZHEIMER DISEASE; CHOLINERGIC SYSTEM; DEMENTIA; DRUG MECHANISM; HUMAN; HYPERSALIVATION; INTOXICATION; MYASTHENIA GRAVIS; REVIEW;

HUMANS; PHARMACEUTICAL PREPARATIONS; POISONING; SALIVARY GLANDS; SIALORRHEA;

EID: 23044466678     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2005.41.6.893628     Document Type: Review

References (52)

1. Bagheri, H., Damase-Michel, C., Lapeyre-Mestre, M. et al. A study of salivary secretion in Parkinson's disease. Clin Neuropharmacol 1999, 22: 213-5.
2. Ben-Aryeh, H., Jungerman, T., Szargel, R., Klein, E., Laufer, D. Salivary flow-rate and composition in schizophrenic patients on clozapine: Subjective reports and laboratory data. Biol Psychiatry 1996, 39: 946-9.
3. Pearlman, C. Clozapine, nocturnal sialorrhea, and choking. J Clin Psychopharmacol 1994, 14: 283.
4. Hinkes, R., Quesada, T.V., Currier, M.B., Gonzales-Blanco, M. Aspiration pneumonia possibly secondary to clozapine-induced sialorrhea. J Clin Psychopharmacol 1996, 16: 462-3.
5. Brodkin, E.S., Pelton, G.H., Price, L.H. Treatment of clozapine-induced parotid gland swelling. Am J Psychiatry 1996, 153: 445.
6. Robinson, D., Fenn, H., Yesavage, J. Possible association of parotitis with clozapine. Am J Psychiatry 1995, 152: 297-8.
7. Baum, B.J., Wellner, R.B. Receptors in salivary glands. In: Garrett, J.R., Ekstrom, J., Anderson, L.C. (Eds.). Neural mechanisms of salivary gland secretion. Basel: Karger 1999, 44-58.
8. Bymaster, F.P., Felder, C.C., Tzavara, E., Nomikos, G.G., Calligaro, D.O., Mckinzie, D.L. Muscarinic mechanisms of antipsychotic atypicality. Prog Neuro-Psychopharmacol Biol Psychiatry 2003, 27: 1125-43.
9. Donaldson, S.R. Sialorrhea as a side effect of lithium: A case report. Am J Psychiatry 1982, 139: 1350-1.
10. Wyllie, E., Wyllie, R., Cruse, R.P., Rothner, A.D., Erenberg, G. The mechanism of nitrazepam-induced drooling and aspiration. N Engl J Med 1986, 314: 35-8.
11. Gajwani, P., Franco-Bronson, K., Tesar, G.E. Risperidone-induced sialorrhea. Psychosomatics 2001, 42: 276.
12. Perkins, D.O., McClure, R.K. Hypersalivation coincident with olanzapine treatment. Am J Psychiatry 1998, 155: 993-4.
13. Szabadi, E. Clozapine-induced hypersalivation. Br J Psychiatry 1997, 171: 89.
14. Corrigan, F.M., MacDonald, S., Reynolds, G.P. Clozapine-induced hypersalivation and the alpha 2 adrenoreceptor. Br J Psychiatry 1995, 169: 380-1.
15. Olianas, M.C., Maullu, C., Onali, P. Mixed agonist-antagonist properties of clozapine at different human cloned muscarinic receptor subtypes expressed in Chinese hamster ovary cells. Neuropsychopharmacology 1999, 20: 263-70.
16. Rabinowitz, T., Frankenburg, F.R., Centorrino, F., Kando, J. The effect of clozapine on saliva flow rate: A pilot study. Biol Psychiatry 1996, 40: 1132-4.
17. Aden-Abdi, Y., Gustafsson, L.L., Elmi, S.A. A simplified dosage schedule of metrifonate in the treatment of Schistosoma haematobium infection in Somalia. Eur J Clin Pharmacol 1987, 32: 437-41.
18. Drachman, D.B. Myasthenia gravis. N Engl J Med 1994, 330: 1797-810.
19. Gorsky, M., Epstein, J.B., Parry, J., Epstein, M.S., Le, N.D., Silverman, Jr. S. The efficacy of pilocarpine and bethanechol upon saliva production in cancer patients with hyposalivation following radiation therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004, 97: 190-5.
20. Chatelut, E., Rispail, Y., Berlan, M., Montastruc, J.L. Yohimbine increases human salivary secretion. Br J Clin Pharmacol 1989, 28: 366-8.
21. Bagheri, H., Schmitt, L., Berlan, M., Montastruc, J.L. Effect of 3 weeks treatment with yohimbine on salivary secretion in healthy volunteers and in depressed patients treated with tricyclic antidepressants. Br J Clin Pharmacol 1992, 34: 555-8.
22. Palmer, J.B., Drennan, J.C., Baba, M. Evaluation and treatment of swallowing impairments. Am Fam Physician 2000, 61: 2453-62.
23. Solis, M.T., Yuen, E., Cortez, P.S., Goebel, P.J. Family poisoned by mercury vapor inhalation. Am J Emerg Med 2000, 18: 599-602.
24. Clarkson, T.W., Magos, L., Myers, G.J. The toxicology of mercury - Current exposures and clinical manifestations. N Engl J Med 2003, 349: 1731-7.
25. Doherty, M.J. The quicksilver price. Mercury vapor poisoning aboard HMS Triumph and HMS Phipps. Neurology 2004, 62: 963-6.
26. Brown, Jr. J.S. Environmental and chemical toxins and psychiatric illness. American Psychiatric Publishing, Inc., Washington, D.C., 2002.
27. Kales, S.N., Christiani, D.C. Acute chemical emergencies. N Engl J Med 2004, 350: 800-8.
28. McCarron, M.M., Schulze, B.W., Thompson, G.A., Conder, M.C., Goetz, W.A. Acute phencyclidine intoxication: Incidence of clinical findings in 1,000 cases. Ann Emerg Med 1981, 10: 237-42.
29. Davis, D.P., Williams, S.R. Amanita muscaria. J Emerg Med 1999, 17: 739.
30. Thomas-Stonell, N., Greenberg, J. Three treatment approaches and clinical factors in the reduction of drooling. Dysphagia 1988, 3: 73-8.
31. Conry, A., Siris, S.G., Bermanzohn, P.C. Improvement of clozapine-induced sialorrhea after septoplasty. Am J Psychiatry 1996, 153: 444.
32. Bourgeois, J.A., Drexler, K.G., Hall, M.J. Hypersalivation and clozapine. Hosp Community Psychiatry 1991, 42: 1174.
33. Copp, P.J., Lament, R., Tennent, T.G. Amitriptyline in clozapine-induced sialorrhea. Br J Psychiatry 1991, 159: 166.
34. Spivak, B., Adlerberg, S., Rosen, L., Gonen, N., Mester, R., Weizman, A. Trihexyphenidyl treatment of clozapine-induced hypersalivation. Int Clin Psychopharmacol 1997, 12: 213-5.
35. Freudenreich, O., Goff, D.C. Colon perforation and peritonitis associated with clozapine. J Clin Psychiatry 2000, 61: 950-1.
36. de Leon, J., Odom-White, A., Josiassen, R.C., Diaz, F.J., Cooper, T.B., Simpson, G.M. Serum antimuscarinic activity during clozapine treatment. J Clin Psychopharmacol 2003, 23: 336-41.
37. Fritze, J., Ellinger, T. Pirenzepine for clozapine-induced hypersalivation. Lancet 1995, 346: 1034.
38. Bai, Y.M., Lin, C.C., Chen, J.Y., Liu, W.C. Therapeutic effect of pirenzepine for clozapine-induced hypersalivation: A randomized, double-blind, placebo-controlled, cross-over study. J Clin Psychopharmacol 2001, 21: 608-11.
39. Calderon, J., Rubin, E., Sobota, W.L. Potential use of ipratropium bromide for the treatment of clozapine-induced hypersalivation: A preliminary report. Int Clin Psychopharmacol 2000, 15: 49-52.
40. Tessier, P., Antonello, C. Clozapine and sialorrhea: Update. J Psychiatry Neurosci 2001, 26: 253.
41. Freudenreich, O., Beebe, M., Goff, D.C. Clozapine-induced sialorrhea treated with sublingual ipratropium spray: A case series. J Clin Psychopharmacol 2004, 24: 98-100.
42. Blasco, P.A., Stansbury, J.C. Glycopyrrolate treatment of chronic drooling. Arch Pediatr Adolesc Med 1996, 150: 932-5.
43. Olsen, A.K., Sjogren, P. Oral glycopyrrolate alleviates drooling in a patient with tongue cancer. J Pain Symptom Manage 1999, 18: 300-2.
44. Mier, R.J., Bachrach, S.J., Lakin, R.C., Barker, T., Childs, J., Moran, M. Treatment of sialorrhea with glycopyrrolate: A double-blind, dose-ranging study. Arch Pediatr Adolesc Med 2000,154: 1214-8.
45. Talmi, Y.P., Finkelstein, Y., Zohar, Y. Reduction of salivary flow with transdermal scopolamine: A four-year experience. Otolaryngol Head Neck Surg 1990, 103: 615-8.
46. Gaftanyuk, O., Trestman, R.L. Scopolamine patch for clozapine-induced sialorrhea. Psychiatr Serv 2004, 55: 318.
47. McKane, J.P., Hall, C., Akram, G. Hyoscine patches in clozapine-induced hypersalivation. Psychiatr Bull 2001, 25: 277.
48. Grabowski, J. Clonidine treatment of clozapine-induced hypersalivation. J Clin Psychopharmacol 1992, 12: 69-70.
49. Webber, M.A., Szwast, S.J., Steadman, T.M. et al. Guanfacine treatment of clozapine-induced sialorrhea. J Clin Psychopharmacol 2004, 24: 675-6.
50. Lipp, A., Trottenberg, T., Schink, T., Kupsch, A., Arnold, G. A randomized trial of botulinum toxin A for treatment of drooling. Neurology 2003, 61: 1279-81.
51. Kahl, K.G., Hagenah, J., Zapf, S., Trillenberg, P., Klein, C., Lencer, R. Botulinum toxin as an effective treatment of clozapine-induced hypersalivation. Psychopharmacology 2004, 173: 229-30.
52. Hockstein, N.G., Samadi, D.S., Gendron, K., Handler, S.D. Sialorrhea: A management challenge. Am Fam Physician 2004, 69: 2628-34.